Editors' declarations of interest
Systematic review with meta-analysis: non-alcoholic steatohepatitis - a case for personalised treatment based on pathogenic targets
Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease
Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms
Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
Anaemia in inflammatory bowel disease: a population-based 10-year follow-up
Bleeding-related symptoms in colorectal cancer: a 4-year nationwide population-based study
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir
Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
Polymorphisms of interferon- λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C
Commentary: broadening the focus of coeliac management to follow-up strategies
Letter: acute severe ulcerative colitis - should all patients be treated equally?
Letter: acute severe ulcerative colitis - should all patients be treated equally?
Letter: guidelines for the management of autoimmune hepatitis
Letter: guidelines for the management of autoimmune hepatitis
Letter: flu-like illness with mercaptopurine and azathioprine in inflammatory bowel disease